Skip to main content

Herbal Extract

Tetrahydromagnolol

Also known as: Magnolia officinalis extract, Magnolol hydrogenation product, Tetrahydro-magnolol, Magnolia bark extract

C
Evidence

A semi-synthetic derivative or bioactive from Magnolia officinalis bark that exhibits anxiolytic and neuroprotective properties. Often studied as part of magnolia bark extract formulations for relaxation and emotional support.

Find the best Tetrahydromagnolol supplements — free
See Tetrahydromagnolol products scored on dose & form, then track your intake in the app.
Open app →

Primary uses

  • Anxiety and stress relief
  • Relaxation and mood support
  • Sleep quality improvement
  • Neuroprotection

How it works

  • GABAergic modulation (GABA receptor agonism)
  • Anxiolytic activity via limbic system
  • Reduction of cortisol and stress markers
  • Antioxidant and anti-inflammatory effects
  • Potential monoamine modulation

Dosage

Typical range
100–300 mg daily (as formulated; exact dosage varies by product)
Timing
Evening or as needed for relaxation; may take 2–4 weeks for adaptation
With food
Can be taken with or without food
Duration
Regular use typically recommended; no established upper limit, but long-term safety data is limited
Special populations
Pregnancy/nursing: avoid; pediatrics: insufficient data

Forms

  • Proprietary extract· 70/100
  • Standardized bark derivative· 70/100
  • Capsule· 70/100
  • Often in multi-ingredient formulas· 70/100

Safety

Common side effects

  • Generally well tolerated at recommended doses
  • Drowsiness (desired effect in some contexts)
  • Rare headache or GI upset

Contraindications

  • Pregnancy and lactation
  • Driving or operating machinery if sedation occurs
  • Concurrent use with strong sedatives without medical guidance

Products containing Tetrahydromagnolol

Top-scoring supplements in our catalog that list Tetrahydromagnolol on the label. Each product is graded on Formulate's ingredient-level rubric — dose accuracy, form, transparency, and third-party testing.

See all products →

Evidence notes

Limited clinical trials specifically on tetrahydromagnolol; most evidence derives from magnolia bark extract and honokiol/magnolol studies. Animal and in vitro data support mechanism, but robust human RCTs are lacking for this isolated derivative.

Grade C: Mostly observational or small trials; mechanism is plausible but unproven at scale.

Related in Herbal Extract

Check a full stack

Formulate's free interaction checker lets you paste in any combination of supplements and medications at once — every pairing flags severity, timing, and cited evidence.

Open the checker

Medical disclaimer. This page is educational and does not replace advice from a qualified healthcare provider.